GlassScriptPhysician profile
Abdul Rana
NPI 1356837363
$8,173.80
in general payments reported to CMS, 2019-2025
6 companies · $8,079 in 2025
The $8,079 reported for 2025 was more than what 91% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $94.87 · 2025: $8,079.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,170 · Travel and Lodging: $818 · Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,170.00 |
| Travel and Lodging | $818.40 |
| Food and Beverage | $185.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,888.19 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $170.00 | 2025 | Dupixent |
| Resmed Corp | $42.07 | 2024 | |
| Becton, Dickinson and Company | $38.46 | 2025 | Hemosphere |
| Pulmonx Corporation | $19.18 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.90 | 2025 | Ofev |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdul Rana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.